English

Kidneys & Diabetes | Dr. Vishwanath S | Manipal Hospital Old Airport Road

In this video, Dr. Vishwanath S, HOD & Consultant – Nephrology and Transplant Physician at Manipal Hospital Old Airport Road, Bengaluru, highlights that diabetes is the leading cause of kidney disease in India. With rising diabetes rates, especially among younger people, the risk of developing diabetic kidney disease increases the longer the condition persists. Previously, treatments such as ACE inhibitors and ARBs were the mainstay for kidney protection, but newer medications have expanded options significantly. Recent advances include SGLT2 inhibitors, which reduce proteinuria and slow kidney dysfunction, and finerenone, recently approved and available in India in 10 mg and 20 mg doses. These drugs complement standard therapies and provide additional kidney and cardiovascular protection. Alongside medication, controlling blood sugar and blood pressure, avoiding unnecessary painkillers, quitting smoking, and regular monitoring remain essential. All patients with diabetes should screen for kidney disease, check creatinine and GFR (which should be above 60), and monitor for proteinuria. Early intervention with ACE inhibitors, ARBs, SGLT2 inhibitors, and finerenone can help prevent progression to dialysis or transplant, ensuring better long-term kidney and heart health.